Latest news
Another tough quarter for Fiserv may lead to product changes - American BankerAmerican Banker · Fri, 07 Aug 2026 19:47:00 GMTKeyBanc Capital Adjusts Price Target on ResMed to $255 From $260 - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 15:26:28 GMTBMO Capital Adjusts Parker-Hannifin Price Target to $1,214 From $1,068 - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 15:00:52 GMTRaymond James Adjusts Price Target on Block to $97 From $90 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 15:57:06 GMTKeyBanc Capital Adjusts Price Target on Block to $108 From $105 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 15:54:55 GMTBMO Capital Adjusts Solventum Price Target to $84 From $81 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 15:28:22 GMTRBC Capital Adjusts PT on United Therapeutics to $677 From $704, Maintains Outperform Rating - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:51:28 GMT5 Must-Read Analyst Questions From Federal Signal’s Q2 Earnings Call - TradingViewTradingView · Thu, 06 Aug 2026 05:47:00 GMT